In a study conducted on 44 breast cancer patients, plasma TGF-β1 levels were significantly elevated in advanced-stage (stage IIIB and IV) patients compared with healthy participants, regardless of BC subtype [61]. This evidence concerns the gene TGFB1 and breast carcinoma.